Visit our new Alternative Investment section.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick pickshVIVO Company Timeline (HVO)

Share Price Information for hVIVO (HVO)

Share Price is delayed by 15 minutes
Get Live Data
7.50    0.05 (0.67%)
Bid:
7.40
Ask:
7.60
Spread: 0.20 (2.703%)
Market Cap: £51.63m
HVO Live PriceLast checked at - London Stock Exchange

Intraday hVIVO Share Chart

Latest Timeline Updates for hVIVO

HVO

RNS
13 May 2026 13:40
hVIVO

Date:
13-May-26

Time:
1:40 pm

Source:
RNS

HVO

RNS
12 May 2026 09:45
hVIVO

Date:
12-May-26

Time:
9:45 am

Source:
RNS

HVO

Broker Rating
7 May 2026 14:35
hVIVO

Date:
07-May-26

Broker:
Stifel

Recommendation:
Hold

Old Target:
10.00

New Target:
10.00

Rating Type:
Reiteration

HVO

News
7 May 2026 12:12
hVIVO

EARNINGS AND TRADING: MHA expects profit beat; hVIVO wins work

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

HVO

News
7 May 2026 11:18
hVIVO

hVIVO signs £6m influenza clinical trial deal

(Sharecast News) - hVIVO announced on Thursday that it has signed a £6m clinical trial agreement with a clinical-stage biopharmaceutical company to conduct an influenza human challenge trial.

HVO

News
7 May 2026 09:55
hVIVO

WINNERS & LOSERS: S4 Capital hit by "client caution"; NAHL in profit

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday.

HVO

RNS
7 May 2026 07:00
hVIVO

Date:
07-May-26

Time:
7:00 am

Source:
RNS

HVO

RNS
24 Apr 2026 18:14
hVIVO

Date:
24-Apr-26

Time:
6:14 pm

Source:
RNS

HVO

Directors Deal
24 Apr 2026 17:25
hVIVO

Date:
24-Apr-26

Action:
Sell

Notifier:
Brendan Buckley
(Non-Executive Director)

Price:
8.65

Amount:
2,017,000

Holding:
6,017,539

HVO

News
22 Apr 2026 18:29
hVIVO

EARNINGS & TRADING: Rift Helium trading on AIM, raises GBP8.1 million

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

HVO

News
22 Apr 2026 16:11
hVIVO

hVIVO secures large whooping cough vaccine test contract

(Sharecast News) - hVIVO said on Wednesday that it has secured a contract to conduct what it described as the world's first pivotal phase three human challenge trial for a whooping cough vaccine, mark...

HVO

Broker Rating
22 Apr 2026 14:45
hVIVO

Date:
22-Apr-26

Broker:
Shore Capital

Recommendation:
Buy

Old Target:
-

New Target:
-

Rating Type:
Reiteration

HVO

RNS
22 Apr 2026 07:00
hVIVO

Date:
22-Apr-26

Time:
7:00 am

Source:
RNS